Actavis and ASKA Establish Company in Japan
Actavis Group and ASKA Pharmaceutical have signed an agreement to establish Actavis ASKA KK. The latter will hold 55 percent of shares in the joint venture, while the former will own 45 percent. The joint company will enter the Japanese generic pharmaceutical market in April 2009.
- Share this article
- Got more on this story? Email PharmaAsia
- More About
- Alliances and Mergers
- Actavis
- ASKA
- KK
